Press Releases for SPNC

Press Releases
Spectranetics Reports Third Quarter Revenue Up 7% to $28.8 Million
Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2009 Financial Results
Spectranetics to Present at Canaccord Adams’ 29th Annual Global Growth Conference on August 12
Spectranetics Reports Second Quarter Revenue of $29 Million
Spectranetics to Hold 2009 Second Quarter Financial Results Conference Call on July 23
Spectranetics Announces First Human Uses of Turbo-Tandem™ System
Spectranetics Announces FDA Clearance to Market Turbo-Tandem™ System
Spectranetics Names Jason Hein Senior VP, Sales, Marketing and Product Development
Spectranetics Receives CE Mark Approval for ThromCat®XT
Spectranetics Reports 15% Revenue Growth in First Quarter 2009
Spectranetics Makes Pre-IDE Submission to FDA for the Treatment of In-Stent Restenosis in the Legs
Data Shows Laser Assisted Lead Removal Effective: Spectranetics Releases Data from LExICon Study
Spectranetics to Hold 2009 First Quarter Financial Results Conference Call on May 6
Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results
Spectranetics Appoints William Jennings and Anne Melissa Dowling as Independent Directors
Spectranetics Reports Financial Results for Fourth Quarter and Full Year 2008
Spectranetics to Hold 2008 Fourth Quarter Financial Results Conference Call on February 19
Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs
Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
Spectranetics Reports Preliminary Revenue for Fourth Quarter and Full-Year 2008
Spectranetics’ International, B.V. Achieves New Sales Milestone
Spectranetics Cross-Pilot Product Receives FDA Clearance
Spectranetics Quick-Cross Extreme Product Line Receives FDA Clearance
Milberg LLP Continues Its Investigation On Behalf of Certain Investors of Spectranetics Corporation
Brower Piven Announces Expanded Class Period and Encourages Investors Who Have Losses in Excess of $100,000 From Investment in The Spectranetics Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the November 24, 2008 Lead Plaintiff Deadline
Cohen, Milstein, Hausfeld & Toll, P.L.L.C. Files Class Action Lawsuit Against The Spectranetics Corp.
Spectranetics Receives NASDAQ Notice
Hagens Berman Sobol Shapiro: Class Action Filed Against Spectranetics
Spectranetics Third Quarter Revenue up 26% to $26.8 Million
Holzer Holzer & Fistel, LLC Announces That a Shareholder Class Action Lawsuit Has Been Filed Against The Spectranetics Corporation (NASDAQ: SPNC)
Spectranetics to Hold 2008 Third Quarter Financial Results Conference Call on October 29
Milberg LLP Announces Its Investigation on Behalf of Certain Investors of Spectranetics Corporation
Kensey Nash Reports First Quarter Fiscal Year 2009 Results
Spectranetics Appoints Company Chairman, Emile J. Geisenheimer, as President and Chief Executive Officer
Glancy Binkow & Goldberg LLP, Representing Shareholders of The Spectranetics Corporation, Announces an Expanded Class Period in the Shareholder Lawsuit
Bronstein, Gewirtz & Grossman, LLC Announces that a Class Action has been Filed Against The Spectranetics Corporation
Shareholder Class Action Filed Against The Spectranetics Corporation by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Kensey Nash Accomplishes First Milestone Under Spectranetics Agreements
Glancy Binkow & Goldberg LLP, Who Filed the Initial Complaint Representing Shareholders of The Spectranetics Corporation, Announces Update to Shareholder Lawsuit
Law Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit Against The Spectranetics Corporation -- SPNC
Bronstein, Gewirtz & Grossman, LLC Announces That a Class Action Has Been Filed Against The Spectranetics Corporation
Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in The Spectranetics Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the November 24, 2008 Lead Plaintiff Deadline
Hagens Berman Sobol Shapiro Files Securities Fraud Suit Against Spectranetics as Whistleblower Comes Forward and SEC Requests Information
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Spectranetics Corporation
Labaton Sucharow Files Class Action Lawsuit Against the Spectranetics Corporation -- SPNC
Izard Nobel LLP Announces Class Action Lawsuit Against The Spectranetics Corporation
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against The Spectranetics Corporation
Spectranetics Announces Securities Lawsuits and Commission Inquiry
Denver-Based Dyer & Berens LLP Files Class Action Lawsuit On Behalf of Certain Investors in The Spectranetics Corporation -- SPNC
Law Offices of Brodsky & Smith, LLC Announces Class Action Lawsuit Against the Spectranetics Corporation
Federman & Sherwood Confirms Filing of a Securities Class Action Lawsuit Against The Spectranetics Corp. (NASDAQ: SPNC)
Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased The Spectranetics Corporation, Announces Class Action Lawsuit and Seeks to Recover Losses -- SPNC
Spectranetics Provides Update on VIVA II: SALVAGE Trial
BellwetherReport.Com Analyst Opinions on SPNC, SNDK, IMMU and ENLV
Spectranetics Announces Federal Investigation
Spectranetics Announces First Laser Lead Extraction Procedures in Japan
Spectranetics Takes Steps Targeted at Accelerating Vascular Intervention Growth
Spectranetics to Present at Canaccord Adams' 28th Annual Global Growth Conference on August 13
Spectranetics Second Quarter Revenue up 31% to $26.7 Million, Driven by Solid Performance across All Business Lines
CORRECTING and REPLACING Spectranetics to Hold 2008 Second Quarter Financial Results Conference Call on July 29
Spectranetics to Hold 2008 Second Quarter Financial Results Conference Call on July 29
Zacks Analyst Blog Highlights: NVIDIA Corp, Sunoco Logistics Partners, L.P., ExxonMobil Corp., Spectranetics Corp. And Medtronic Inc.
Spectranetics Appoints Michael Voss as Vice President and General Manager of Vascular Intervention Business
Spectranetics Ranked Among America's Fastest-Growing Small Companies for Third Year in a Row by FORTUNE Small Business
Spectranetics Enrolls First Patients in TAAMI Trial
Spectranetics to Present at the Goldman Sachs and Jefferies Healthcare Conferences in June
Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics
Spectranetics Announces Closing of Transaction to Acquire Endovascular Business of Kensey Nash
Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads - May 27 2008 12:54AM
Spectranetics to Present at the Citi Investment Research Global Health Care Conference on May 22 - Jun 2 2008 4:37AM
Spectranetics Acquires Endovascular Business of Kensey Nash - May 27 2008 12:41AM
Kensey Nash Announces Sale of Endovascular Business and Strategic Partnership With Spectranetics - May 27 2008 12:41AM
Safe Options for Cardiac Lead Removal: Study Published in Heart Rhythm Journal - Jun 2 2008 4:37AM
Spectranetics Reaches Settlement with Medtronic
Spectranetics First Quarter Revenue up 37% to $23.8 Million, Driven by Strong Vascular Intervention and Lead Management Performance
Spectranetics to Hold 2008 First Quarter Financial Results Conference Call on April 23